About

Romiplostim is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It works by stimulating the production of platelets in the bone marrow, thereby increasing platelet counts and reducing the risk of bleeding. Administered via subcutaneous injection, Romiplostim offers a targeted approach to managing ITP by mimicking the natural thrombopoietin protein. Its mechanism of action involves binding to and activating the thrombopoietin receptor, leading to the proliferation and differentiation of megakaryocytes, which are the precursor cells to platelets. This results in a sustained increase in platelet levels, helping patients maintain adequate hemostasis and improve their quality of life by reducing the frequency and severity of bleeding episodes.

Uses

Treatment of chronic immune thrombocytopenia (ITP).
Increasing platelet counts in ITP patients.
Reducing the risk of bleeding in ITP.
For patients unresponsive to other ITP therapies.

Directions For Use

Administer subcutaneously as directed by a healthcare professional. Dosage is individualized based on platelet count.

Benefits

Effectively increases platelet counts.
Reduces the incidence of bleeding events.
Improves quality of life for ITP patients.
Offers a targeted mechanism of action.
Suitable for long-term management of chronic ITP.
Administered conveniently via subcutaneous injection.

Side Effects

Headache
Arthralgia
Dizziness
Insomnia
Myalgia
Pain in extremity
Abdominal pain
Shoulder pain
Paresthesia
Dyspepsia
Increased risk of thrombosis
Bone marrow reticulin deposition

Safety Measures

Alcohol - Avoid or limit alcohol consumption as it may exacerbate bleeding risk or interact with medication effects.
Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus; consult a physician.
Breastfeeding - Exercise caution; it is unknown if Romiplostim is excreted in human milk. Consult a doctor.
Liver - Use with caution in patients with hepatic impairment; close monitoring may be required.
Kidney - Use with caution in patients with renal impairment; dosage adjustments may be necessary.
Lung - No specific contraindications, but monitor for any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location